Your shopping cart is currently empty

NP-BTA, an allosteric inhibitor of glutaminyl-tRNA synthetase (GlnRS), demonstrates antifungal activity against Candida albicans, with a MIC50 of 6.25 μM [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | NP-BTA, an allosteric inhibitor of glutaminyl-tRNA synthetase (GlnRS), demonstrates antifungal activity against Candida albicans, with a MIC50 of 6.25 μM [1]. |
| In vitro | NP-BTA (300 μM) inhibits GlnRS by binding with His6-Gln4 (K D of 180 nM), thereby preventing the aminoacylation of tRNA Gln, with an IC 50 of 106 nM [1]. |
| In vivo | NP-BTA (0.096–0.27 g 2% NP-BTA cream, applied twice daily for 7 days) helps protect immunosuppressed CD-1 mice from infection by T. mentagrophytes conidia [1]. Animal Model: Immunosuppressed CD-1 mice infected with T. mentagrophytes [1] Dosage: 0.096–0.27 g 2% NP-BTA cream Administration: Topical application, twice daily for 7 days Result: Reduced fungal burden. |
| Molecular Weight | 231.27 |
| Formula | C11H9N3OS |
| Cas No. | 544420-99-7 |
| Smiles | C(=CC(NC=1N=CC=CN1)=O)C2=CC=CS2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.